Apollo Endosurgery Inc (APEN) Gross Profit Margin starting from the fourth quarter 2022 to fourth quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Apollo Endosurgery inc   (NASDAQ: APEN)


Apollo Endosurgery Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APEN Gross Profit Margin (Dec 31 2022)
Q4 		(Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4
Y / Y Revenue Change 31.8 %
Seq. Revenue Change 8.89 %
Revenue In Millions $21.31
Gross Profit Margin 53.28 %
Gross Profit Margin Total Ranking # 1718
Gross Profit In Millions $11.36
Y / Y Gross Profit Change 24.77 %
Seq. Gross Profit Change 5.76 %


Commenting fourth quarter 2022 Gross Profit Margin
Apollo Endosurgery Inc has managed to improve its Revenue sequentially to $21.31 millions by 8.89 % faster than Gross Profit increase of 5.76 % to $11.36 millions, this led to contraction in Gross Profit Margin to 53.28 %, below company average.


Observing fourth quarter 2022 results within Medical Equipment & Supplies industry 118 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1705 to 1718.
Learn about Gross Margin
APEN's Gross Profit Margin fourth quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 119
Healthcare Sector # 342
Overall # 1687

Gross Profit Margin Statistics
High Average Low
58.38 % 53.29 % 43.04 %
(Mar 31 2018)   (Jun 30 2020)


APEN Gross Income Trends • More of APEN's Profitabilty Ratios • APEN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
APEN's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
APEN's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for APEN's Competitors
Gross Profit Margin Profit Margin for Apollo Endosurgery Inc 's Suppliers
Gross Profit Margin Profit Margin for APEN's Customers

You may also want to know
APEN's Annual Growth Rates APEN's Profitability Ratios APEN's Asset Turnover Ratio APEN's Dividend Growth
APEN's Roe APEN's Valuation Ratios APEN's Financial Strength Ratios APEN's Gross Profit Growth
APEN's Roa APEN's Inventory Turnover Ratio APEN's Growth Rates APEN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within Medical Equipment & Supplies Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue
Oak Street Health Inc   98.29 %$ 567.800  Millions$ 577.700  Millions
Sintx Technologies Inc   96.21 %$ 0.736  Millions$ 0.765  Millions
Endonovo Therapeutics Inc   95.99 %$ 0.117  Millions$ 0.121  Millions
Semler Scientific inc   91.44 %$ 12.614  Millions$ 13.795  Millions
Shockwave Medical Inc   87.85 %$ 126.524  Millions$ 144.026  Millions
Inari Medical Inc   87.82 %$ 94.643  Millions$ 107.771  Millions
Vycor Medical Inc   86.30 %$ 0.234  Millions$ 0.271  Millions
Avita Medical Inc   85.75 %$ 8.108  Millions$ 9.455  Millions
Sanara Medtech Inc   84.53 %$ 12.947  Millions$ 15.316  Millions
Si bone inc   84.07 %$ 26.864  Millions$ 31.953  Millions
Inspire Medical Systems inc   83.94 %$ 115.748  Millions$ 137.900  Millions
Inmode Ltd   83.82 %$ 380.786  Millions$ 454.271  Millions
Fonar Corporation  83.41 %$ 20.233  Millions$ 24.256  Millions
Axogen inc   83.02 %$ 30.023  Millions$ 36.164  Millions
Nuo Therapeutics Inc   82.81 %$ 0.061  Millions$ 0.074  Millions
Sight Sciences Inc   82.17 %$ 16.880  Millions$ 20.544  Millions
Nexalin Technology Inc   82.11 %$ 0.032  Millions$ 0.038  Millions
Paragon 28 inc   81.97 %$ 42.221  Millions$ 51.508  Millions
Cerus Corporation  81.71 %$ 87.094  Millions$ 106.592  Millions
Edwards Lifesciences Corporation  80.87 %$ 1,090.400  Millions$ 1,348.300  Millions
Zynex inc   80.76 %$ 39.417  Millions$ 48.805  Millions
Mimedx Group Inc   80.68 %$ 60.006  Millions$ 74.375  Millions
Treace Medical Concepts Inc   80.43 %$ 40.027  Millions$ 49.769  Millions
Streamex Corp   80.00 %$ 0.108  Millions$ 0.135  Millions
Cvrx inc   78.97 %$ 5.667  Millions$ 7.176  Millions
Surmodics Inc   78.88 %$ 19.666  Millions$ 24.933  Millions
Electromedical Technologies Inc   78.68 %$ 0.333  Millions$ 0.423  Millions
Staar Surgical Co  77.74 %$ 49.785  Millions$ 64.044  Millions
Novocure Limited  77.51 %$ 99.541  Millions$ 128.429  Millions
Neuronetics Inc   75.88 %$ 13.809  Millions$ 18.198  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.